Getting Mounjaro in Scotland: NHS Criteria, Private Access and How the Process Works

Step 1: Understanding how Scotland handles NHS access to Mounjaro

A common assumption is that NICE approvals automatically unlock NHS treatment across the whole of the UK the moment they're published. In practice, health policy in Scotland is devolved: NHS Scotland sets its own guidance through the Scottish Medicines Consortium (SMC) and individual health boards, and this doesn't always move in step with NICE decisions in England.

NICE's tirzepatide appraisal (TA1026, December 2024) applies to NHS England and, in slightly different form, to Wales and Northern Ireland through their own processes, and if you're based across the Irish Sea you can read more about how Mounjaro is handled in Northern Ireland specifically. Scotland's NHS pathway for weight-management medicines like Mounjaro runs through specialist obesity services, and availability depends on which health board you're under and what tier of support they can offer. NHS Inform Scotland gives a useful starting point for understanding how diabetes and weight-loss medicines are managed in Scottish healthcare. Waiting times through those specialist pathways can stretch to months or longer in many areas.

The practical upshot: if you live in Scotland and want to explore treatment now rather than join a waiting list, a private prescription from a regulated online pharmacy is worth understanding as a parallel option.

Step 2: Checking whether you'd be eligible for a private Mounjaro prescription

Private prescribing for Mounjaro follows the medicine's UK licence, which is set by the MHRA, not devolved by nation. So the same eligibility framework applies whether you're in Glasgow, Aberdeen or anywhere else. The licence covers adults with a BMI of 30 or above, or 27 and above where there's at least one weight-related health condition such as high blood pressure, high cholesterol, prediabetes, type 2 diabetes or obstructive sleep apnoea.

BMI is the starting point, not the whole picture. A prescriber reviews your health history, any medicines you already take, and whether there are any contraindications, certain conditions, including a personal or family history of medullary thyroid carcinoma or MEN2, mean tirzepatide isn't appropriate. Pregnancy, breastfeeding, or actively trying to conceive are also situations where it isn't recommended. Nor is it licensed for anyone under 18.

You can get a rough sense of where you stand using the NHS BMI calculator before starting a consultation, though the prescriber's assessment is what counts. If you'd like to read more about the treatment in detail, the tirzepatide overview covers the clinical background and how the medicine works.

Step 3: How a private prescription through a regulated pharmacy actually works

The process is straightforward, though it does involve real clinical steps, it isn't a matter of filling in a form and waiting for a parcel. At nume, you complete a free consultation online. A GPhC-registered Independent Prescriber reads your answers the same day. Not software, not an automated scoring system, a named clinician who decides whether treatment is suitable for you.

If approved, your prescription is written, dispensed at our GPhC-registered pharmacy (registration 9012878, verifiable at the GPhC register), and dispatched the same day for orders placed before noon Monday to Friday. Delivery is free, tracked via DPD, and arrives the next working day in plain, unbranded packaging, including to Scottish addresses. Every repeat order is clinically re-reviewed before dispatch; there are no automatic renewals.

If cost is a factor in your thinking, our treatment pricing page sets out what's included in one transparent price. Worth knowing that legitimate private prescriptions for Mounjaro include the clinical consultation and prescription in addition to the medicine itself, services advertising unusually low prices are worth scrutinising carefully.

Step 4: What to be aware of once treatment starts

Mounjaro's side-effect profile is well characterised. The most commonly reported effects are gastrointestinal: nausea and stomach discomfort tend to show up most in the early weeks, often settling as the body adjusts. Constipation, loose stools and heartburn are also reported. These are usually mild to moderate and ease over time, particularly because treatment starts at the lowest dose specifically to help with tolerability, and you can find a full breakdown of what to expect when you begin on the Mounjaro 2.5 mg starting dose.

A few symptoms warrant prompt medical attention rather than waiting it out: severe stomach pain that extends to the back (a potential sign of pancreatitis), signs of a serious allergic reaction, or significant dehydration following vomiting or diarrhoea. The NHS tirzepatide information page lists these clearly. If you experience something you're uncertain about while on treatment, our clinical team is available for aftercare seven days a week. You can also report suspected side effects to the MHRA's Yellow Card scheme at any point.

People sometimes ask whether living in Scotland affects their aftercare options or their ability to have their GP notified. It doesn't. GP notification follows standard GPhC guidance regardless of where in Scotland you're based, and our prescribers liaise with your GP in line with that. Some people also have questions about particular aspects of their health alongside treatment, including those wondering about Mounjaro and erectile dysfunction, which our dedicated page addresses in detail. If you have specific questions about how treatment fits alongside other health conditions or medicines, the FAQs cover many common scenarios, or you can get in touch directly.

Ready to find out if you're suitable? Check your eligibility with a free consultation today. If you're already established on treatment and looking ahead, our page on moving to the Mounjaro 5 mg dose explains what that next step involves.